Inhibitex (INHX) Trudges Higher, Now Down ~20%; Dec./Jan. Puts Draw Interest
Tweet
Share
E-mailGet Alerts INHX Hot Sheet
Join SI Premium – FREE
After being down as much as 36.6 percent Friday following Pharmasset amending its QUANTUM trial, Inhibitex (Nasdaq: INHX) are comfortably off of lows.
Shares are now down just over 20 percent, to $10.32 per share.
Notably, the price of December 12.5 put options ripped 1400 percent higher today, the last sale at $2.25.
Shares are now down just over 20 percent, to $10.32 per share.
Notably, the price of December 12.5 put options ripped 1400 percent higher today, the last sale at $2.25.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AST SpaceMobile (ASTS) call put ratio 4.2 calls to 1 put with a focus on August 7 weekly 70 calls into quarter results
- Global S&P Futures mixed in premarket
- Alcoa (AA) September 60 calls active, share price up 4.3%
Create E-mail Alert Related Categories
Insiders' Blog, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
